Cancer Letters Journal Citation Rate 2026
0304-3835
eISSN 1872-7980
Elsevier BV
NL
Approx. Q1 Quartile Top Tier
About Cancer Letters
Cancer Letters (CL) is an academic journal covering Cancer, Hypoxia, and Metabolism and Cancer-related Molecular Pathways, published by Elsevier BV in NL, catalogued under ISSN 0304-3835 (e-ISSN 1872-7980). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 8.60 (approximate Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4100 USD). OpenAlex records 19,260 works and 802,446 citations, with an h-index of 269.
Cancer Letters Citation Rate 2026 — In Context
Cancer Letters has a 2025 2-Year Citation Rate (OpenAlex) of 8.60, placing it in the approximate Q1 quartile within the Cancer, Hypoxia, and Metabolism research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Cancer Letters operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Cancer Letters should review the journal's submission tips and check the latest indexing status at the source (the Scopus Sources list, DOAJ and Web of Science); our indexing tracker shows the OpenAlex and DOAJ coverage we hold. To compare Cancer Letters against similar journals in the field, use our journal comparison tool.
Submission Tips for Cancer Letters
- Budget $4100 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Letters Compares
Compared against 147 journals in the same research areas.
| ISSN (Print) | 0304-3835 |
|---|---|
| ISSN (Online) | 1872-7980 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| APC / Cost | $4100 USD |
| h-index | 282 |
| Total Works | 19,237 |
| Total Citations | 869,565 |
| 2-yr Mean Citedness | 10.97 (OpenAlex) |
In-depth profile & metrics
Cancer Letters is published by Elsevier BV and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4100.
In our subject taxonomy, Cancer Letters is classified under Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies and Human auditory perception and evaluation.
Cancer Letters is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
OpenAlex records 19,237 works that have together drawn 869,565 citations, giving the journal an h-index of 282; its most recent citation rate stands at 8.599; OpenAlex puts its two-year mean citedness at 10.97.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer Letters
OpenAlex and DOAJ Coverage
Updated April 2026OpenAlex and DOAJ coverage we hold for this journal. Check other databases at the source.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 8.599 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex and DOAJ and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 598 | 56,506 |
| 2024 | 624 | 57,111 |
| 2023 | 378 | 54,034 |
| 2022 | 366 | 55,604 |
| 2021 | 474 | 56,405 |
| 2020 | 495 | 51,067 |
| 2019 | 480 | 42,070 |
| 2018 | 547 | 38,182 |
| 2017 | 509 | 37,100 |
| 2016 | 527 | 34,483 |
| 2015 | 489 | 33,357 |
| 2014 | 485 | 31,844 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Cancer Letters most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Compare Journals
Compare Cancer Letters against similar publications in its field:
Related Journals in Your Field
-
Chemical Society Reviews The Royal Society of Chemistry IF 31.04
-
Advanced Drug Delivery Reviews Elsevier BV IF 12.22
-
Pharmacology & Therapeutics Elsevier BV IF 10.38
-
Journal of Experimental & Clinical Cancer Research BioMed Central IF 10.31
-
Business Horizons Elsevier BV IF 8.87
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S106234763
Get weekly updates for Cancer, Hypoxia, and Metabolism journals
Free. Monday morning. New citation rates, CFPs, updates on journals you track, predatory watch list. One-click unsubscribe.